Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia

Arthritis Care and Research

Volumn 64, Issue 11, 2012, Pages 1730-1738

  Palmsten, Kristin ^a   Hernández Díaz, Sonia ^a   Kuriya, Bindee ^b   Solomon, Daniel H ^c   Setoguchi, Soko ^c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; ENTERITIS; FEMALE; GESTATIONAL AGE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PREECLAMPSIA; PREGNANCY; PSORIASIS; REFERENCE DATABASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; BRITISH COLUMBIA; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH SERVICES; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84868258151     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21807     Document Type: Article

References (46)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M,. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437-45.
2. Skomsvoll JF, Ostensen M, Irgens LM, Baste V,. Pregnancy complications and delivery practice in women with connective tissue disease and inflammatory rheumatic disease in Norway. Acta Obstet Gynecol Scand 2000; 79: 490-5.
3. Chakravarty EF, Nelson L, Krishnan E,. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006; 54: 899-907.
4. Clowse ME, Jamison M, Myers E, James AH,. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008; 199: 127. e121-6.
5. Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES,. Association of rheumatologic disease with preeclampsia. Obstet Gynecol 2004; 103: 1190-3.
6. Lin HC, Chen SF, Chen YH,. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 2012; 69: 715-7.
7. Kelly VM, Nelson LM, Chakravarty EF,. Obstetric outcomes in women with multiple sclerosis and epilepsy. Neurology 2009; 73: 1831-6.
8. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA,. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007; 133: 1106-12.
9. Ferguson CB, Mahsud-Dornan S, Patterson RN,. Inflammatory bowel disease in pregnancy. BMJ 2008; 337: a427.
10. Ostensen M, Forger F,. Management of RA medications in pregnant patients. Nat Rev Rheumatol 2009; 5: 382-90.
11. Redman CW, Sargent IL,. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-4.
12. Kuriya B, Hernandez-Diaz S, Liu J, Bermas BL, Daniel G, Solomon DH,. Patterns of medication use during pregnancy in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011; 63: 721-8.
13. Van Runnard Heimel PJ, Kavelaars A, Heijnen CJ, Peters WH, Huisjes AJ, Franx A, et al. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens Pregnancy 2008; 27: 253-65.
14. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA,. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791-8.
15. Hanley GE, Morgan S,. On the validity of area-based income measures to proxy household income. BMC Health Serv Res 2010; 8: 79.
16. Bergsjo P, Denman DW III, Hoffman HJ, Meirik O,. Duration of human singleton pregnancy: a population-based study. Acta Obstet Gynecol Scand 1990; 69: 197-207.
17. Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernandez-Diaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf 2012. E-pub ahead of print.
18. Taylor AL, Watson CJ, Bradley JA,. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005; 56: 23-46.
19. Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y,. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol 2012; 42: 145-53.
20. Colozza M, de Azambuja E, Cardoso F, Bernard C, Piccart MJ,. Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era. Oncologist 2006; 11: 111-25.
21. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY,. Pregnancy hypertension. In:, Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, editors. Williams Obstetrics. 23rd ed. New York: McGraw-Hill; 2010.
22. Geller SE, Ahmed S, Brown ML, Cox SM, Rosenberg D, Kilpatrick SJ,. International Classification of Diseases-9th revision coding for preeclampsia: how accurate is it? Am J Obstet Gynecol 2004; 190: 1629-33.
23. Yasmeen S, Romano PS, Schembri ME, Keyzer JM, Gilbert WM,. Accuracy of obstetric diagnoses and procedures in hospital discharge data. Am J Obstet Gynecol 2006; 194: 992-1001.
24. Ros HS, Cnattingius S, Lipworth L,. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998; 147: 1062-70.
25. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46: 328-46.
26. Redman CW, Sargent IL,. Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63: 534-43.
27. Caplan L, Wolfe F, Russell AS, Michaud K,. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J Rheumatol 2007; 34: 696-705.
28. Klarenbeek NB, van der Kooij SM, Guler-Yuksel M, van Groenendael JH, Han KH, Kerstens PJ, et al. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis 2011; 70: 315-9.
29. Duckitt K, Harrington D,. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565.
30. Ting G, Schneeweiss S, Katz JN, Weinblatt ME, Cabral D, Scranton RE, et al. Performance of a rheumatoid arthritis records-based index of severity. J Rheumatol 2005; 32: 1679-87.
31. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ,. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-64.
32. Zou G,. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.
33. Zeger SL, Liang KY,. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-30.
34. Hernandez-Diaz S, Toh S, Cnattingius S,. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 2009; 338: b2255.
35. Wallis AB, Saftlas AF, Hsia J, Atrash HK,. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008; 21: 521-6.
36. Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD,. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 2002; 155: 203-9.
37. De Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009; 60: 3196-206.
38. Sargent IL, Borzychowski AM, Redman CW,. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online 2006; 13: 680-6.
39. Bonelli M, Smolen JS, Scheinecker C,. Treg and lupus. Ann Rheum Dis 2010; 69 Suppl: i65-6.
40. Guerin LR, Prins JR, Robertson SA,. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update 2009; 15: 517-35.
41. Petersen EE, Rasmussen SA, Daniel KL, Yazdy MM, Honein MA,. Prescription medication borrowing and sharing among women of reproductive age. J Womens Health 2008; 17: 1073-80.
42. Daleboudt GM, Broadbent E, McQueen F, Kaptein AA,. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63: 342-50.
43. Harrold LR, Andrade SE,. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 2009; 38: 396-402.
44. Toh S, Mitchell AA, Werler MM, Hernandez-Diaz S,. Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception. Am J Epidemiol 2008; 167: 633-40.
45. Ananth CV, Peedicayil A, Savitz DA,. Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-for-gestational-age births. Epidemiology 1995; 6: 391-5.
46. Ananth CV, Savitz DA, Luther ER, Bowes WA Jr., Preeclampsia and preterm birth subtypes in Nova Scotia, 1986 to 1992. Am J Perinatol 1997; 14: 17-23.